Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002075298-25-000006
Filing Date
2025-12-03
Accepted
2025-12-03 21:04:56
Documents
1
Period of Report
2025-12-03

Document Format Files

Seq Description Document Type Size
1 form4-12042025_021252.html 4  
1 form4-12042025_021252.xml 4 3799
  Complete submission text file 0002075298-25-000006.txt   5337
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ALECTOR, INC. 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address
Berkley Neil Lindsay (Reporting) CIK: 0002075298 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38792 | Film No.: 251548062